Physician profile
Laura Smith
NPI 1407502396
$10,558.39
in general payments reported to CMS, 2019-2025
37 companies · $4,002 in 2025
The $4,002 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,236 · 2023: $2,488 · 2024: $2,832 · 2025: $4,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,121 · Consulting Fee: $150 · Education: $51.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,120.64 |
| Consulting Fee | $150.00 |
| Education | $51.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,948.01 | 2022-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,541.83 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $978.73 | 2022-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Genzyme Corporation | $790.15 | 2022-2025 | |
| Harmony Biosciences LLC | $630.31 | 2023-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $518.25 | 2023-2025 | Dupixent |
| Insmed, INC. | $467.96 | 2023-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $406.99 | 2022-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $325.58 | 2022-2025 | |
| Pulmonx Corporation | $297.21 | 2024-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Viatris Specialty LLC | $268.62 | 2025 | Yupelri |
| Amgen INC. | $205.80 | 2022-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $204.16 | 2022-2024 | |
| United Therapeutics Corporation | $170.42 | 2022-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $152.92 | 2023-2025 | Acthar, Terlivaz |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $151.26 | 2022-2025 | Glassia |
| Genentech USA, INC. | $143.49 | 2022-2025 | Xolair |
| Zoll Respicardia, INC. | $140.80 | 2023-2024 | Remede System |
| Atricure, INC. | $122.15 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Idorsia Pharmaceuticals US INC | $120.78 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $117.78 | 2022-2025 | Winrevair, Belsomra |
| La Jolla Pharmaceutical Company | $105.46 | 2022-2023 | Giapreza |
| Verona Pharma, INC. | $105.42 | 2025 | Ohtuvayre |
| Grifols USA, LLC | $96.54 | 2025 | Prolastin-C Liquid |
| Baxter Healthcare | $79.38 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $68.66 | 2024-2025 | Uptravi, Opsynvi, Opsumit |
| Novartis Pharmaceuticals Corporation | $53.89 | 2025 | |
| Gilead Sciences, INC. | $52.49 | 2023 | |
| Electromed, INC. | $50.05 | 2024 | Smartvest |
| Lilly USA, LLC | $44.39 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $42.47 | 2024-2025 | Inspire |
| Ani Pharmaceuticals, INC. | $33.10 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $32.09 | 2022-2025 | |
| Shionogi INC | $29.21 | 2023 | Fetroja |
| Avadel Cns Pharmaceuticals, LLC | $22.00 | 2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $21.40 | 2023 | Xarelto |
| Liquidia Technologies, INC. | $18.64 | 2025 | Yutrepia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.